图书馆订阅: Guest
Begell Digital Portal Begell 数字图书馆 电子图书 期刊 参考文献及会议录 研究收集
生物,工程和医学的道德
SJR: 0.123

ISSN 打印: 2151-805X
ISSN 在线: 2151-8068

生物,工程和医学的道德

DOI: 10.1615/EthicsBiologyEngMed.2016016260
pages 263-279

Cutting Eugenics Out of CRISPR-Cas9

Carolyn Brokowski
Bioethics (Medical Ethics) Department, Columbia University School of Professional Studies, New York, New York
Marya Pollack
Department of Psychiatry, Columbia University College of Physicians and Surgeons, Inwood Clinic, New York, New York
Robert Pollack
Biological Sciences Department, Columbia University School of the Arts, New York, New York

ABSTRACT

The use of clustered regularly interspaced short palindromic repeats (CRISPR) and their associated (Cas) proteins (the CRISPR-Cas system) in genomic engineering is among the most promising biomedical innovations to occur in the last few decades. One of this system's most profound features is its ability to edit genomes with impressive specificity, which may cause significant alterations of cellular, tissue, and organismal phenotypes at the near instance of the editing, over the lifespan of the organism and potentially into any number of future generations. We argue that the use of the CRISPR-Cas9 system to edit the human germline should be legally prohibited on account of the system's potential for generating an unjust eugenic future. Its use in nongermline experimentation and applications, however, should not be constrained on eugenic grounds. Such a blanket legal prohibition might limit the progress gleaned from this technology. Allowing experimentation in human subjects more broadly might expose participants to considerable risk and potentially harmful outcomes, and the system might prove unable to realize tangible therapeutic outcomes that seem likely ex ante. We conclude that the uncertainty inherent in CRISPR use should not lead to reflexive, preemptive prohibitions, but instead to ethical, fastidious, and controlled experimentation.


Articles with similar content:

The Medical Case for Gene Editing
Ethics in Biology, Engineering and Medicine: An International Journal, Vol.6, 2015, issue 1-2
Christopher Gyngell, Julian Savulescu
Progress Toward Skeletal Gene Therapy
Critical Reviews™ in Eukaryotic Gene Expression, Vol.14, 2004, issue 1&2
Henry J. Klamut, Shin-Tai Chen, David J. Baylink, K.-H. William Lau
Abstract of "Animal Testing and Clinical Trials for the Subdural Hybrid Neuroprosthesis: Ethical Aspects in the Context of Human History"
Journal of Long-Term Effects of Medical Implants, Vol.18, 2008, issue 1
Nandor Ludvig
Cryonic Life Extension: Scientific Possibility or Stupid Pipe Dream?
Ethics in Biology, Engineering and Medicine: An International Journal, Vol.3, 2012, issue 1-3
John Doyle
Abstract of "Drug-Eluting Stents: Some Lessons for the Ethics of Medical Nanotechnology"
Journal of Long-Term Effects of Medical Implants, Vol.18, 2008, issue 1
George J. Agich